Opioids Treatment Maker Indivior Pleads Guilty, Will Pay $600M

(July 24, 2020, 1:21 PM EDT) -- SLOUGH, England — Drug maker Indivior PLC on July 24 announced that it has agreed to resolve a federal charge and regulatory investigation into false statements about its opioids treatment Suboxone...
To view the full article, register now.